Sampling circulating tumor cells for clinical benefits: How frequent?

10.1186/s13045-015-0174-9

Saved in:
Bibliographic Details
Main Authors: Leong, S.M, Tan, K.M.L, Chua, H.W, Tan, D, Fareda, D, Osmany, S, Li, M.-H, Tucker, S, Koay, E.S.C
Other Authors: PATHOLOGY
Format: Review
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/180906
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-180906
record_format dspace
spelling sg-nus-scholar.10635-1809062024-04-03T07:36:15Z Sampling circulating tumor cells for clinical benefits: How frequent? Leong, S.M Tan, K.M.L Chua, H.W Tan, D Fareda, D Osmany, S Li, M.-H Tucker, S Koay, E.S.C PATHOLOGY tumor marker tumor marker breast cancer cancer diagnosis cancer growth cancer patient cancer prognosis circulating tumor cell clinical decision making colorectal cancer disease course epithelial mesenchymal transition human human cell lung cancer metastasis molecular mechanics ovary cancer prostate cancer Review simulation treatment failure blood metabolism neoplasm pathology tumor embolism Biomarkers, Tumor Humans Neoplasms Neoplastic Cells, Circulating 10.1186/s13045-015-0174-9 Journal of Hematology and Oncology 8 1 75 2020-10-27T05:39:30Z 2020-10-27T05:39:30Z 2015 Review Leong, S.M, Tan, K.M.L, Chua, H.W, Tan, D, Fareda, D, Osmany, S, Li, M.-H, Tucker, S, Koay, E.S.C (2015). Sampling circulating tumor cells for clinical benefits: How frequent?. Journal of Hematology and Oncology 8 (1) : 75. ScholarBank@NUS Repository. https://doi.org/10.1186/s13045-015-0174-9 17568722 https://scholarbank.nus.edu.sg/handle/10635/180906 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic tumor marker
tumor marker
breast cancer
cancer diagnosis
cancer growth
cancer patient
cancer prognosis
circulating tumor cell
clinical decision making
colorectal cancer
disease course
epithelial mesenchymal transition
human
human cell
lung cancer
metastasis
molecular mechanics
ovary cancer
prostate cancer
Review
simulation
treatment failure
blood
metabolism
neoplasm
pathology
tumor embolism
Biomarkers, Tumor
Humans
Neoplasms
Neoplastic Cells, Circulating
spellingShingle tumor marker
tumor marker
breast cancer
cancer diagnosis
cancer growth
cancer patient
cancer prognosis
circulating tumor cell
clinical decision making
colorectal cancer
disease course
epithelial mesenchymal transition
human
human cell
lung cancer
metastasis
molecular mechanics
ovary cancer
prostate cancer
Review
simulation
treatment failure
blood
metabolism
neoplasm
pathology
tumor embolism
Biomarkers, Tumor
Humans
Neoplasms
Neoplastic Cells, Circulating
Leong, S.M
Tan, K.M.L
Chua, H.W
Tan, D
Fareda, D
Osmany, S
Li, M.-H
Tucker, S
Koay, E.S.C
Sampling circulating tumor cells for clinical benefits: How frequent?
description 10.1186/s13045-015-0174-9
author2 PATHOLOGY
author_facet PATHOLOGY
Leong, S.M
Tan, K.M.L
Chua, H.W
Tan, D
Fareda, D
Osmany, S
Li, M.-H
Tucker, S
Koay, E.S.C
format Review
author Leong, S.M
Tan, K.M.L
Chua, H.W
Tan, D
Fareda, D
Osmany, S
Li, M.-H
Tucker, S
Koay, E.S.C
author_sort Leong, S.M
title Sampling circulating tumor cells for clinical benefits: How frequent?
title_short Sampling circulating tumor cells for clinical benefits: How frequent?
title_full Sampling circulating tumor cells for clinical benefits: How frequent?
title_fullStr Sampling circulating tumor cells for clinical benefits: How frequent?
title_full_unstemmed Sampling circulating tumor cells for clinical benefits: How frequent?
title_sort sampling circulating tumor cells for clinical benefits: how frequent?
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/180906
_version_ 1795374526562828288